257 related articles for article (PubMed ID: 33705801)
1. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
[TBL] [Abstract][Full Text] [Related]
2. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
4. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
[TBL] [Abstract][Full Text] [Related]
5. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
Connor M; Bagley EE; Chieng BC; Christie MJ
Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents.
Altarifi AA; David B; Muchhala KH; Blough BE; Akbarali H; Negus SS
J Psychopharmacol; 2017 Jun; 31(6):730-739. PubMed ID: 28142305
[TBL] [Abstract][Full Text] [Related]
7. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
[TBL] [Abstract][Full Text] [Related]
8. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.
Bohn LM; Lefkowitz RJ; Caron MG
J Neurosci; 2002 Dec; 22(23):10494-500. PubMed ID: 12451149
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons.
Tan M; Walwyn WM; Evans CJ; Xie CW
J Biol Chem; 2009 Mar; 284(10):6270-81. PubMed ID: 19126537
[TBL] [Abstract][Full Text] [Related]
10. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
11. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
12. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
[TBL] [Abstract][Full Text] [Related]
13. Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.
Koshimizu TA; Honda K; Nagaoka-Uozumi S; Ichimura A; Kimura I; Nakaya M; Sakai N; Shibata K; Ushijima K; Fujimura A; Hirasawa A; Kurose H; Tsujimoto G; Tanoue A; Takano Y
Nat Neurosci; 2018 Jun; 21(6):820-833. PubMed ID: 29713080
[TBL] [Abstract][Full Text] [Related]
14. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
[TBL] [Abstract][Full Text] [Related]
15. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance.
Zhang X; Bao L; Guan JS
Trends Pharmacol Sci; 2006 Jun; 27(6):324-9. PubMed ID: 16678916
[TBL] [Abstract][Full Text] [Related]
16. The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels.
Yudin Y; Rohacs T
Br J Pharmacol; 2019 Sep; 176(17):3110-3125. PubMed ID: 31074038
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Characters of Oliceridine, a μ-Opioid Receptor G-Protein-Biased Ligand in Mice.
Liang DY; Li WW; Nwaneshiudu C; Irvine KA; Clark JD
Anesth Analg; 2019 Nov; 129(5):1414-1421. PubMed ID: 30044299
[TBL] [Abstract][Full Text] [Related]
19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
20. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors.
Montilla-García Á; Perazzoli G; Tejada MÁ; González-Cano R; Sánchez-Fernández C; Cobos EJ; Baeyens JM
Neuropharmacology; 2018 Jun; 135():328-342. PubMed ID: 29580951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]